YM529/ONO-5920

YM529 · Astellas Pharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YM529/ONO-5920, covering 2015-05-04 to 2015-05-04. Get the full timeline:

Most recent: Clinical Trial Update: ONO-5920/YM529 Confirmatory Study in Involutional Osteoporosis Patients [Phase 2, Phase 3]